Evidence map›Paper›PMID 31461929›Full record

ArticleMarine drugs2019

Recombinant N-acyl homoserine lactone-Lactonase AiiA

Bao Zhang, Xiyi Zhuang, Liyun Guo, Robert J C McLean, Weihua Chu

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. EngineeredFrontiers in microbiology · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Sanguinarine Protects Channel Catfish againstPathogens (Basel, Switzerland) · 2022
    Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Bao ZhangDepartment of Pharmaceutical Microbiology, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.
Xiyi ZhuangDepartment of Pharmaceutical Microbiology, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.
Liyun GuoDepartment of Microbiology, Nanjing Institute of Fisheries Science, Nanjing 210036, China.
Robert J C McLeanDepartment of Biology, Texas State University, San Marcos, TX 78666, USA.
Weihua ChuDepartment of Pharmaceutical Microbiology, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China. chuweihua@cpu.edu.cn.ORCID 0000-0003-0055-2035
China Pharmaceutical University · CNTexas State University · US

Funding

National Natural Science Foundation of China 31672676Priority Academic Program Development of Jiangsu Higher Education Institutions PAPD
6 · The paper itself

Abstract

Quorum quenching (QQ) is a promising alternative infection-control strategy to antibiotics that controls quorum-regulated virulence without killing the pathogens.

Indexed as

4-ButyrolactoneAdministration, OralAeromonas hydrophilaAnimal FeedAnimalsAnti-Bacterial AgentsBacterial ProteinsBiofilmsCarpsCell LineCloning, MolecularFish DiseasesFisheriesGram-Negative Bacterial InfectionsMetalloendopeptidasesQuorum Sensing4-ButyrolactoneAiiA protein, BacillusAnti-Bacterial AgentsBacterial Proteinshomoserine lactoneMetalloendopeptidasesRecombinant ProteinsVirulence FactorsAeromonas hydrophilabiofilmCrucian CarpN-acyl homoserine lactone lactonasevirulence factors

Identifiers

PMID31461929
PMCPMC6780897
OpenAlexW2970475417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.